Literature DB >> 25367936

IGF1R signaling is a therapeutic target in ALK fusion-positive lung cancer.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25367936     DOI： 10.1158/2159-8290.CD-RW2014-191

Source DB:  PubMed          Journal:  Cancer Discov        ISSN： 2159-8274            Impact factor:   39.397


× No keyword cloud information.
  1 in total

1.  miR-100 inhibits the migration and invasion of nasopharyngeal carcinoma by targeting IGF1R.

Authors:  Xiaoyan Sun; Xiaoying Liu; Yanmei Wang; Shuqin Yang; Yao Chen; Tiejun Yuan
Journal:  Oncol Lett       Date:  2018-04-04       Impact factor: 2.967
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.